Conference Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 555 - Novel Methods in Estimation Enhancement
Type: Contributed
Date/Time: Thursday, August 11, 2022 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract #322307
Title: Robustly Leveraging the Post-Randomization Information to Improve Precision in the Analyses of Randomized Clinical Trials
Author(s): Yu Du* and Bingkai Wang
Companies: Eli Lilly and Company and University of Pennsylvania
Keywords: MMRM; ANCOVA; Stratified Randomization; Average Treatment Effect; Missing Data; Covariate Adjustment
Abstract:

In randomized clinical trials, repeated measures of the outcome are routinely collected. The mixed model for repeated measures (MMRM) leverages the information from these repeated outcome measures, and is often used for the primary analysis to estimate the average treatment effect at the final visit. MMRM, however, can suffer from precision loss when it models the intermediate outcomes incorrectly, and hence fails to use the post-randomization information in a harmless way. In this paper, we propose a new working model within the MMRM framework, called IMMRM, that optimizes the precision gain from covariate adjustment, stratified randomization and adjustment for intermediate outcome measures. We prove that the IMMRM estimator for the average treatment effect is consistent and asymptotically normal under arbitrary misspecification of its working model assuming missing completely at random. Under simple or stratified randomization, the IMMRM estimator is asymptotically equally or more precise than the analysis of covariance (ANCOVA) estimator and the other MMRM estimators. The simulation studies considering both MCAR and MAR demonstrated the superiority of employing IMMRM estimator.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2022 program